Effect of Shan Zha (Hawthorn or Crataegus) on gastrointestinal cancer: A network pharmacology and molecular docking study

Background: Shan Zha (Hawthorn or Crataegus) is a traditional Chinese medicine (TCM) most commonly used for the treatment of hyperlipidemia. Gastrointestinal cancer is closely correlated with blood lipid levels. This study illustrates the potential anticancer effects of Shan Zha on gastrointestinal...

Full description

Bibliographic Details
Main Authors: Jing Yang, Jialin Gu, Ying Shen, Ling Cao, Hong Zhou, Wei Zhu
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Cancer Pathogenesis and Therapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S294971322300006X
_version_ 1797653646832304128
author Jing Yang
Jialin Gu
Ying Shen
Ling Cao
Hong Zhou
Wei Zhu
author_facet Jing Yang
Jialin Gu
Ying Shen
Ling Cao
Hong Zhou
Wei Zhu
author_sort Jing Yang
collection DOAJ
description Background: Shan Zha (Hawthorn or Crataegus) is a traditional Chinese medicine (TCM) most commonly used for the treatment of hyperlipidemia. Gastrointestinal cancer is closely correlated with blood lipid levels. This study illustrates the potential anticancer effects of Shan Zha on gastrointestinal tumors based on network pharmacology and molecular docking. Methods: Hawthorn's bioactive ingredients and drug targets were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), Integrative Pharmacology-based Research Platform of Traditional Chinese Medicine version 2.0 (TCMIP v2.0), and Herbal Ingredients' Targets Platform (HIT 2.0) databases. Validated disease targets of gastrointestinal cancer were obtained from the Therapeutic Targets Database (TTD) and HIT 2.0 databases. Protein–protein interaction analysis of intersecting genes was performed using the Search Tool for the Retrieval of Interacting Genes (STRING) database. The functions of these genes were further analyzed by performing gene ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. Molecular docking verification was performed using Molecular Operating Environment (MOE) software. Results: Four main bioactive components were identified in Shan Zha. A total of 271 potential drug targets were identified, and 393 gastrointestinal-tumor targets were obtained. Through protein interaction analysis of intersecting targets, the main components of Shan Zha were found to interact more closely with proteins such as tumor protein p53 (TP53), AKT serine/threonine kinase 1 (AKT1), JUN proto-oncogene (JUN), interleukin 6 (IL6), epidermal growth factor receptor (EGFR), and vascular endothelial growth factor A (VEGFA). KEGG pathway enrichment analysis showed a total of 127 pathways, mainly involving pathways in multiple types of cancer, the Phosphatidylinositol 3-kinase-Akt (PI3K-Akt) signaling pathway, and EGFR tyrosine kinase inhibitor resistance. Combined with The Cancer Genome Atlas (TCGA) differential analysis, key targets, including TP53, cyclin D1 (CCND1), EGFR, and VEGFA, were screened. Molecular docking results showed that quercetin and kaempferol had the good binding potential for TP53, CCND1, EGFR, and VEGFA. Conclusion: These findings suggest that Shan Zha exerts its effects on gastrointestinal cancers through a multitarget, multi-component, and a multi-pathway mechanism.
first_indexed 2024-03-11T16:47:36Z
format Article
id doaj.art-d2f2f20b23e840b0b375759b90d5dc0a
institution Directory Open Access Journal
issn 2949-7132
language English
last_indexed 2024-03-11T16:47:36Z
publishDate 2023-10-01
publisher Elsevier
record_format Article
series Cancer Pathogenesis and Therapy
spelling doaj.art-d2f2f20b23e840b0b375759b90d5dc0a2023-10-22T04:50:08ZengElsevierCancer Pathogenesis and Therapy2949-71322023-10-0114229237Effect of Shan Zha (Hawthorn or Crataegus) on gastrointestinal cancer: A network pharmacology and molecular docking studyJing Yang0Jialin Gu1Ying Shen2Ling Cao3Hong Zhou4Wei Zhu5Oncology Center, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Wujiang, Jiangsu 215228, ChinaDepartment of Traditional Chinese Medicine, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Wujiang, Jiangsu 215228, ChinaDepartment of Endocrinology, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Wujiang, Jiangsu 215228, ChinaOncology Center, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Wujiang, Jiangsu 215228, ChinaOncology Center, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Wujiang, Jiangsu 215228, China; Corresponding author: Oncology Center, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Wujiang, Jiangsu 215228, China.Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China; Corresponding author: Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.Background: Shan Zha (Hawthorn or Crataegus) is a traditional Chinese medicine (TCM) most commonly used for the treatment of hyperlipidemia. Gastrointestinal cancer is closely correlated with blood lipid levels. This study illustrates the potential anticancer effects of Shan Zha on gastrointestinal tumors based on network pharmacology and molecular docking. Methods: Hawthorn's bioactive ingredients and drug targets were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), Integrative Pharmacology-based Research Platform of Traditional Chinese Medicine version 2.0 (TCMIP v2.0), and Herbal Ingredients' Targets Platform (HIT 2.0) databases. Validated disease targets of gastrointestinal cancer were obtained from the Therapeutic Targets Database (TTD) and HIT 2.0 databases. Protein–protein interaction analysis of intersecting genes was performed using the Search Tool for the Retrieval of Interacting Genes (STRING) database. The functions of these genes were further analyzed by performing gene ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. Molecular docking verification was performed using Molecular Operating Environment (MOE) software. Results: Four main bioactive components were identified in Shan Zha. A total of 271 potential drug targets were identified, and 393 gastrointestinal-tumor targets were obtained. Through protein interaction analysis of intersecting targets, the main components of Shan Zha were found to interact more closely with proteins such as tumor protein p53 (TP53), AKT serine/threonine kinase 1 (AKT1), JUN proto-oncogene (JUN), interleukin 6 (IL6), epidermal growth factor receptor (EGFR), and vascular endothelial growth factor A (VEGFA). KEGG pathway enrichment analysis showed a total of 127 pathways, mainly involving pathways in multiple types of cancer, the Phosphatidylinositol 3-kinase-Akt (PI3K-Akt) signaling pathway, and EGFR tyrosine kinase inhibitor resistance. Combined with The Cancer Genome Atlas (TCGA) differential analysis, key targets, including TP53, cyclin D1 (CCND1), EGFR, and VEGFA, were screened. Molecular docking results showed that quercetin and kaempferol had the good binding potential for TP53, CCND1, EGFR, and VEGFA. Conclusion: These findings suggest that Shan Zha exerts its effects on gastrointestinal cancers through a multitarget, multi-component, and a multi-pathway mechanism.http://www.sciencedirect.com/science/article/pii/S294971322300006XCrataegusGastrointestinal cancerHawthornMolecular dockingNetwork pharmacologyShan Zha
spellingShingle Jing Yang
Jialin Gu
Ying Shen
Ling Cao
Hong Zhou
Wei Zhu
Effect of Shan Zha (Hawthorn or Crataegus) on gastrointestinal cancer: A network pharmacology and molecular docking study
Cancer Pathogenesis and Therapy
Crataegus
Gastrointestinal cancer
Hawthorn
Molecular docking
Network pharmacology
Shan Zha
title Effect of Shan Zha (Hawthorn or Crataegus) on gastrointestinal cancer: A network pharmacology and molecular docking study
title_full Effect of Shan Zha (Hawthorn or Crataegus) on gastrointestinal cancer: A network pharmacology and molecular docking study
title_fullStr Effect of Shan Zha (Hawthorn or Crataegus) on gastrointestinal cancer: A network pharmacology and molecular docking study
title_full_unstemmed Effect of Shan Zha (Hawthorn or Crataegus) on gastrointestinal cancer: A network pharmacology and molecular docking study
title_short Effect of Shan Zha (Hawthorn or Crataegus) on gastrointestinal cancer: A network pharmacology and molecular docking study
title_sort effect of shan zha hawthorn or crataegus on gastrointestinal cancer a network pharmacology and molecular docking study
topic Crataegus
Gastrointestinal cancer
Hawthorn
Molecular docking
Network pharmacology
Shan Zha
url http://www.sciencedirect.com/science/article/pii/S294971322300006X
work_keys_str_mv AT jingyang effectofshanzhahawthornorcrataegusongastrointestinalcanceranetworkpharmacologyandmoleculardockingstudy
AT jialingu effectofshanzhahawthornorcrataegusongastrointestinalcanceranetworkpharmacologyandmoleculardockingstudy
AT yingshen effectofshanzhahawthornorcrataegusongastrointestinalcanceranetworkpharmacologyandmoleculardockingstudy
AT lingcao effectofshanzhahawthornorcrataegusongastrointestinalcanceranetworkpharmacologyandmoleculardockingstudy
AT hongzhou effectofshanzhahawthornorcrataegusongastrointestinalcanceranetworkpharmacologyandmoleculardockingstudy
AT weizhu effectofshanzhahawthornorcrataegusongastrointestinalcanceranetworkpharmacologyandmoleculardockingstudy